Look up the positivity rates for Wyoming if you want to your eyes to pop out of their sockets.The positivity rate in my county is now over 20%. Our hospitals are now at maximum capacity.
Nor should most Americans. But in theory, a patient person could choose between 3 or even 4 approved vaccines before next fall?I'm not personally willing to wait until late 21 or into 22 for a recombinant subunit vaccine.
Like I said, my buddy isn't an anti-vaxxer and he understands the topic well enough. He just objects to anything DNA-related with no prior track record to bank on. I personally don't think society has much choice in this matter; but like I said, a patient person could hold off a few months longer then the earliest general availability.
If I'm not mistaken, Moderna is quoting $36 per dose. Pfizer's has the well-known cold-chain challenges. So realistically, the AZ/Oxford candidate is the real game changer for the world based on low-cost and simpler, widespread distribution.
I wonder if at $36 per dose, Moderna is realistically able to sell 1B doses in 2021? But that's really a concern for their shareholders, as it looks like the world will have options.